Cancer

RSS

Progress in Sugen's cancer development pipeline

Jan. 9, 1997

OXiGENE and Boston Medical Center announce collaboration

Jan. 9, 1997

Vion receives SBIR grant to develop ribonucleotide reductase inhibitor

Jan. 9, 1997

KGF receptor antagonists developed by U.S. researchers

Jan. 9, 1997

BCH-4556 slated to enter clinical testing

Jan. 8, 1997

Pharmacyclics completes phase I testing of Lu-Tex

Jan. 8, 1997

Draxis acquires Canadian rights to Mylan's paclitaxel formulation

Jan. 8, 1997

New form of DNA linked to prostate cancer

Jan. 8, 1997

Joint venture formed to develop cancer therapy

Jan. 7, 1997

NeoRx technology receives additional patent

Jan. 7, 1997